Crystallization scale preparation of a stable GPCR signaling complex between constitutively active rhodopsin and G-protein

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Maeda, Shoji ^a,b   Sun, Dawei ^a,b   Singhal, Ankita ^a,b   Foggetta, Marcello ^c   Schmid, Georg ^c   Standfuss, Joerg ^a,b   Hennig, Michael ^c   Dawson, Roger J P ^c   Veprintsev, Dmitry B ^a,b   Schertler, Gebhard F X ^a,b  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c Discovery Technologies   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; RHO FACTOR; RHODOPSIN; TRANSDUCIN; PROTEIN BINDING; PROTEIN SUBUNIT;

ARTICLE; CATTLE; CRYSTALLIZATION; GEL PERMEATION CHROMATOGRAPHY; ISOMERIZATION; NONHUMAN; PHOTORECEPTOR; PROTEIN PURIFICATION; PROTEIN STRUCTURE; RETINA; RETINA ROD; SPECTROSCOPY; STOICHIOMETRY; THERMOSTABILITY; ULTRACENTRIFUGATION; VISUAL SYSTEM; ANIMAL; BOVINE; CHEMISTRY; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; MISSENSE MUTATION; PROTEIN STABILITY; PROTEIN SUBUNIT;

ANIMALS; CATTLE; HEK293 CELLS; HUMANS; MUTATION, MISSENSE; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN SUBUNITS; RHODOPSIN; TRANSDUCIN;

EID: 84903642406     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098714     Document Type: Article

References (53)

1. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB (2003) The G-proteincoupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63: 1256-1272.
2. Insel PA, Tang C-M, Hahntow I, Michel MC (2007) Impact of GPCRs in clinical medicine: Monogenic diseases, genetic variants and drug targets. Biochimica et Biophysica Acta (BBA) - Biomembranes 1768: 994-1005.
3. Schöneberg T, Schulz A, Biebermann H, Hermsdorf T, Römpler H, et al. (2004) Mutant G-protein-coupled receptors as a cause of human diseases. Pharmacol Ther 104: 173-206.
4. Hopkins AL, Groom CR (2002) The druggable genome. Nature reviews Drug discovery 1: 727-730.
5. Kobilka B, Schertler GF (2008) New G-protein-coupled receptor crystal structures: insights and limitations. Trends Pharmacol Sci 29: 79-83.
6. Tate CG (2012) A crystal clear solution for determining G-protein-coupled receptor structures. Trends in Biochemical Sciences 37: 343-352.
7. Chun E, Thompson AA, Liu W, Roth CB, Griffith MT, et al. (2012) Fusion partner toolchest for the stabilization and crystallization of g protein-coupled receptors. Structure 20: 967-976.
8. Caffrey M, Li D, Dukkipati A (2012) Membrane protein structure determination using crystallography and lipidic mesophases: recent advances and successes. Biochemistry 51: 6266-6288.
9. Riekel C, Burghammer M, Schertler G (2005) Protein crystallography microdiffraction. Curr Opin Struct Biol 15: 556-562.
10. Moukhametzianov R, Burghammer M, Edwards PC, Petitdemange S, Popov D, et al. (2008) Protein crystallography with a micrometre-sized synchrotronradiation beam. Acta Crystallogr D Biol Crystallogr 64: 158-166.
11. Deupi X, Edwards P, Singhal A, Nickle B, Oprian D, et al. (2012) Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II. Proceedings of the National Academy of Sciences of the United States of America 109: 119-124.
12. Standfuss J, Edwards PC, D'Antona A, Fransen M, Xie G, et al. (2011) The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature 471: 656-660.
13. Choe HW, Kim YJ, Park JH, Morizumi T, Pai EF, et al. (2011) Crystal structure of metarhodopsin II. Nature 471: 651-655.
14. White JF, Noinaj N, Shibata Y, Love J, Kloss B, et al. (2012) Structure of the agonist-bound neurotensin receptor. Nature 490: 508-513.
15. Singhal A, Ostermaier MK, Vishnivetskiy SA, Panneels V, Homan KT, et al. (2013) Insights into congenital stationary night blindness based on the structure of G90D rhodopsin. EMBO reports 14: 520-526.
16. Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, et al. (2011) Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 477: 549-555.
17. Hofmann KP, Scheerer P, Hildebrand PW, Choe HW, Park JH, et al. (2009) A G protein-coupled receptor at work: the rhodopsin model. Trends in Biochemical Sciences 34: 540-552.
18. Kobilka BK, Deupi X (2007) Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 28: 397-406.
19. Baylor DA, Nunn BJ, Schnapf JL (1984) The photocurrent, noise and spectral sensitivity of rods of the monkey Macaca fascicularis. The Journal of physiology 357: 575-607.
20. Melia TJ, Jr., Cowan CW, Angleson JK, Wensel TG (1997) A comparison of the efficiency of G protein activation by ligand-free and light-activated forms of rhodopsin. Biophysical journal 73: 3182-3191.
21. Robinson PR, Cohen GB, Zhukovsky EA, Oprian DD (1992) Constitutively active mutants of rhodopsin. Neuron 9: 719-725.
22. Han M, Sakmar TP (2000) Assays for activation of recombinant expressed opsins by all-trans-retinals. Methods in enzymology 315: 251-267.
23. Xie G, Gross AK, Oprian DD (2003) An opsin mutant with increased thermal stability. Biochemistry 42: 1995-2001.
24. Standfuss J, Xie G, Edwards PC, Burghammer M, Oprian DD, et al. (2007) Crystal structure of a thermally stable rhodopsin mutant. J Mol Biol 372: 1179-1188.
25. Standfuss J, Zaitseva E, Mahalingam M, Vogel R (2008) Structural impact of the E113Q counterion mutation on the activation and deactivation pathways of the G protein-coupled receptor rhodopsin. J Mol Biol 380: 145-157.
26. Han M, Smith SO, Sakmar TP (1998) Constitutive activation of opsin by mutation of methionine 257 on transmembrane helix 6. Biochemistry 37: 8253-8261.
27. Xie G, D'Antona AM, Edwards PC, Fransen M, Standfuss J, et al. (2011) Preparation of an activated rhodopsin/transducin complex using a constitutively active mutant of rhodopsin. Biochemistry 50: 10399-10407.
28. Vogel R, Sakmar TP, Sheves M, Siebert F (2007) Coupling of protonation switches during rhodopsin activation. Photochemistry and photobiology 83: 286-292.
29. Jager F, Fahmy K, Sakmar TP, Siebert F (1994) Identification of glutamic acid 113 as the Schiff base proton acceptor in the metarhodopsin II photointermediate of rhodopsin. Biochemistry 33: 10878-10882.
30. Mahalingam M, Martinez-Mayorga K, Brown MF, Vogel R (2008) Two protonation switches control rhodopsin activation in membranes. Proceedings of the National Academy of Sciences of the United States of America 105: 17795-17800.
31. Kühn H (1984) Interactions between photoexcited rhodopsin and light-activated enzymes in rods. Progress in retinal research 3: 123-156.
32. Jastrzebska B, Goc A, Golczak M, Palczewski K (2009) Phospholipids are needed for the proper formation, stability, and function of the photoactivated rhodopsin-transducin complex. Biochemistry 48: 5159-5170.
33. Ernst OP, Gramse V, Kolbe M, Hofmann KP, Heck M (2007) Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit. Proc Natl Acad Sci U S A 104: 10859-10864.
34. Suda K, Filipek S, Palczewski K, Engel A, Fotiadis D (2004) The supramolecular structure of the GPCR rhodopsin in solution and native disc membranes. Molecular membrane biology 21: 435-446.
35. Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, et al. (2003) Atomicforce microscopy: Rhodopsin dimers in native disc membranes. Nature 421: 127-128.
36. Jastrzebska B, Ringler P, Palczewski K, Engel A (2013) The rhodopsintransducin complex houses two distinct rhodopsin molecules. Journal of structural biology 182: 164-172.
37. Orban T, Jastrzebska B, Gupta S, Wang B, Miyagi M, et al. (2012) Conformational dynamics of activation for the pentameric complex of dimeric G protein-coupled receptor and heterotrimeric G protein. Structure 20: 826-840.
38. Jastrzebska B, Ringler P, Lodowski DT, Moiseenkova-Bell V, Golczak M, et al. (2011) Rhodopsin-transducin heteropentamer: three-dimensional structure and biochemical characterization. Journal of structural biology 176: 387-394.
39. D'Antona AM, Xie G, Sligar SG, Oprian DD (2014) Assembly of an activated rhodopsin-transducin complex in nanoscale lipid bilayers. Biochemistry 53: 127-134.
40. Bayburt TH, Leitz AJ, Xie G, Oprian DD, Sligar SG (2007) Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. J Biol Chem 282: 14875-14881.
41. Alexandrov AI, Mileni M, Chien EY, Hanson MA, Stevens RC (2008) Microscale fluorescent thermal stability assay for membrane proteins. Structure 16: 351-359.
42. Kanaho Y, Tsai SC, Adamik R, Hewlett EL, Moss J, et al. (1984) Rhodopsinenhanced GTPase activity of the inhibitory GTP-binding protein of adenylate cyclase. The Journal of biological chemistry 259: 7378-7381.
43. Hattori M, Hibbs RE, Gouaux E (2012) A fluorescence-detection size-exclusion chromatography-based thermostability assay for membrane protein precrystallization screening. Structure 20: 1293-1299.
44. Jastrzebska B, Golczak M, Fotiadis D, Engel A, Palczewski K (2009) Isolation and functional characterization of a stable complex between photoactivated rhodopsin and the G protein, transducin. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 23: 371-381.
45. Jastrzebska B, Orban T, Golczak M, Engel A, Palczewski K (2013) Asymmetry of the rhodopsin dimer in complex with transducin. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 27: 1572-1584.
46. Westfield GH, Rasmussen SG, Su M, Dutta S, DeVree BT, et al. (2011) Structural flexibility of the G alpha s alpha-helical domain in the beta2-adrenoceptor Gs complex. Proc Natl Acad Sci U S A 108: 16086-16091.
47. Preininger AM, Meiler J, Hamm HE (2013) Conformational flexibility and structural dynamics in GPCR-mediated G protein activation: a perspective. Journal of Molecular Biology 425: 2288-2298.
48. Kruse AC, Ring AM, Manglik A, Hu J, Hu K, et al. (2013) Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature 504: 101-106.
49. Webb DR, Handel TM, Kretz-Rommel A, Stevens RC (2013) Opportunities for functional selectivity in GPCR antibodies. Biochem Pharmacol 85: 147-152.
50. Steyaert J, Kobilka BK (2011) Nanobody stabilization of G protein-coupled receptor conformational states. Current Opinion in Structural Biology 21: 567-572.
51. Reeves PJ, Callewaert N, Contreras R, Khorana HG (2002) Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N- acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc Natl Acad Sci U S A 99: 13419-13424.
52. Wessling-Resnick M, Johnson GL (1987) Allosteric behavior in transducin activation mediated by rhodopsin. Initial rate analysis of guanine nucleotide exchange. The Journal of biological chemistry 262: 3697-3705.
53. Kleuss C, Pallast M, Brendel S, Rosenthal W, Schultz G (1987) Resolution of transducin subunits by chromatography on blue sepharose. Journal of chromatography 407: 281-289.